1. Home
  2. BBAR vs NVAX Comparison

BBAR vs NVAX Comparison

Compare BBAR & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBAR
  • NVAX
  • Stock Information
  • Founded
  • BBAR 1886
  • NVAX 1987
  • Country
  • BBAR Argentina
  • NVAX United States
  • Employees
  • BBAR N/A
  • NVAX N/A
  • Industry
  • BBAR Commercial Banks
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BBAR Finance
  • NVAX Health Care
  • Exchange
  • BBAR Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • BBAR 2.7B
  • NVAX 2.0B
  • IPO Year
  • BBAR N/A
  • NVAX 1995
  • Fundamental
  • Price
  • BBAR $13.57
  • NVAX $9.76
  • Analyst Decision
  • BBAR
  • NVAX Buy
  • Analyst Count
  • BBAR 0
  • NVAX 6
  • Target Price
  • BBAR N/A
  • NVAX $17.83
  • AVG Volume (30 Days)
  • BBAR 597.6K
  • NVAX 7.2M
  • Earning Date
  • BBAR 11-19-2024
  • NVAX 11-07-2024
  • Dividend Yield
  • BBAR 12.13%
  • NVAX N/A
  • EPS Growth
  • BBAR N/A
  • NVAX N/A
  • EPS
  • BBAR 0.24
  • NVAX N/A
  • Revenue
  • BBAR $2,631,545,762.00
  • NVAX $987,667,000.00
  • Revenue This Year
  • BBAR N/A
  • NVAX N/A
  • Revenue Next Year
  • BBAR N/A
  • NVAX N/A
  • P/E Ratio
  • BBAR $22.13
  • NVAX N/A
  • Revenue Growth
  • BBAR N/A
  • NVAX N/A
  • 52 Week Low
  • BBAR $3.86
  • NVAX $3.53
  • 52 Week High
  • BBAR $14.45
  • NVAX $23.86
  • Technical
  • Relative Strength Index (RSI)
  • BBAR 66.75
  • NVAX 36.20
  • Support Level
  • BBAR $11.22
  • NVAX $9.52
  • Resistance Level
  • BBAR $14.45
  • NVAX $10.63
  • Average True Range (ATR)
  • BBAR 0.63
  • NVAX 0.57
  • MACD
  • BBAR 0.21
  • NVAX -0.12
  • Stochastic Oscillator
  • BBAR 70.11
  • NVAX 9.97

About BBAR Banco BBVA Argentina S.A. ADS

Banco BBVA Argentina SA is a banking services provider in Argentina. It provides financial assistance to large corporations, small and medium-sized companies, as well as individuals. It bank provides services through retail, corporate, investment banking, and Small and medium-sized companies divisions. Through the retail banking segment, it provides banking products and services to individuals, corporate banking deals with services to corporates, and the small and medium-sized companies segment focused on foreign trade, agricultural business, and digital products.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

Share on Social Networks: